Molecular medicine in lung cancer
4 Jul 2017
Molecular medicine in lung cancer
Biomarker research in breast cancer
New biomarkers for response to immunotherapy
Combining immune-based therapies with TKIs in melanomas
Current and future immune approaches in precision medicine
Precision medicine enabled histology agnostic development of immunotherapeutics
Incorporating liquid biopsies into clinical trials
DNA damage response inhibition
Big data, scientific wellness and transforming healthcare
Bayesian adaptive trial designs for precision medicine
Redesigning clinical trials in the era of precision medicine
Genomic-driven clinical studies in breast cancer